Literature DB >> 6102688

Drugs and the heart. III. Calcium antagonists.

L H Opie.   

Abstract

Mesh:

Substances:

Year:  1980        PMID: 6102688     DOI: 10.1016/s0140-6736(80)91303-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  32 in total

1.  The effect of combined therapy on the pharmacokinetics and pharmacodynamics of verapamil and propranolol in patients with angina pectoris.

Authors:  J C McCourty; J H Silas; G T Tucker; M S Lennard
Journal:  Br J Clin Pharmacol       Date:  1988-03       Impact factor: 4.335

Review 2.  Digitalis and verapamil in atrial fibrillation and flutter. Is verapamil now the preferred agent?

Authors:  H O Klein; E Kaplinsky
Journal:  Drugs       Date:  1986-03       Impact factor: 9.546

Review 3.  Studies on verapamil in the treatment of essential hypertension: a review.

Authors:  K Midtbø; O Hals; O Lauve; J van der Meer; L Storstein
Journal:  Br J Clin Pharmacol       Date:  1986       Impact factor: 4.335

Review 4.  Adverse reactions to calcium antagonists.

Authors:  J G Lewis
Journal:  Drugs       Date:  1983-02       Impact factor: 9.546

Review 5.  Calcium antagonists. Clinical use in the treatment of systemic hypertension.

Authors:  C Spivack; S Ocken; W H Frishman
Journal:  Drugs       Date:  1983-02       Impact factor: 9.546

6.  Calcium antagonists and the heart.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1981-01-10

7.  Steady-state pharmacokinetics of the enantiomers of perhexiline in CYP2D6 poor and extensive metabolizers administered Rac-perhexiline.

Authors:  Benjamin J Davies; Megan K Herbert; Janet K Coller; Andrew A Somogyi; Robert W Milne; Benedetta C Sallustio
Journal:  Br J Clin Pharmacol       Date:  2007-09-13       Impact factor: 4.335

8.  Interactions between a "calcium channel agonist", Bay K 8644, and calcium antagonists differentiate calcium antagonist subgroups in K+-depolarized smooth muscle.

Authors:  M Spedding; C Berg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-11       Impact factor: 3.000

9.  Assessment of "Ca2+ -antagonist" effects of drugs in K+ -depolarized smooth muscle. Differentiation of antagonist subgroups.

Authors:  M Spedding
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-02       Impact factor: 3.000

10.  A comparison of nine calcium ion antagonists and propranolol: exercise tolerance, heart rate and ST-segment changes in patients with chronic stable angina pectoris.

Authors:  N S Khurmi; E B Raftery
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.